{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T20:41:20Z","timestamp":1725568880732},"reference-count":11,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T00:00:00Z","timestamp":1323302400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asia-Pac J Clncl Oncology"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim:\u2003<\/jats:bold> Recently, a number of studies have demonstrated the effectiveness of a single reduced dose of rasburicase for the management of tumor lysis syndrome (TLS) in adults. Whether Asian lymphoma patients similarly respond to a single dose of rasburicase is currently unknown. We aim to assess the efficacy of a single dose rasburicase in preventing TLS in Asian lymphoma patients.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> This was a single\u2010center case series of adult lymphoma patients at high risk of TLS who received a single fixed dose of rasburicase. Patients had to have their uric acid, serum creatinine, lactate dehydrogenase and electrolytes monitored for at least 24\u201348\u2003h post\u2010administration.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> Eleven patients were identified. Majority were Chinese (91%), male (64%) and with a median age of 61\u2003years (range 41\u201384). All had at least two risk factors for developing TLS. Ten patients received a 6\u2010mg dose and one received 4.5\u2003mg. Prior to rasburicase administration, the mean uric acid level was 835\u2003\u00b5mol\/L (range 318\u20131237\u2003\u00b5mol\/L) and the level 24\u2010h post\u2010administration was 186\u2003\u00b5mol\/L (range 30\u2013653\u2003\u00b5mol\/L) (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001). Eight patients (73%) experienced an improvement of renal function 72\u2010h post\u2010rasburicase. Normalization of serum electrolytes was achieved within 96\u2003h.<\/jats:p><jats:p><jats:bold>Conclusion:\u2003<\/jats:bold> Among Asian lymphoma patients who manifested at least two risk factors for developing TLS, a single fixed dose of rasburicase at 6\u2003mg is deemed to be effective for rapidly lowering uric acid levels as well as sustaining reduced levels for up to 72\u2003h.<\/jats:p>","DOI":"10.1111\/j.1743-7563.2011.01464.x","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T00:36:54Z","timestamp":1323391014000},"page":"351-356","source":"Crossref","is-referenced-by-count":9,"title":["Management of tumor lysis syndrome with a single fixed dose of rasburicase in Asian lymphoma patients: A case series and literature review"],"prefix":"10.1111","volume":"7","author":[{"given":"Joen","family":"CHIANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"CHAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"LIAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"TAY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"QUEK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"TAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon Thye","family":"LIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,12,8]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0581"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402847"},{"key":"e_1_2_5_4_2","unstructured":"Sanofi\u2010Synthelabo.Elitek (rasburicase) product monograph. New York;2005. [cited 16 Aug 2010]. Available from:http:\/\/products.sanofi\u2010aventis.us\/elitek\/elitek.html."},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.2.242"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2004.09.004"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E002"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.28.6.685"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P296"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.8896"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0177"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.6.806"}],"container-title":["Asia-Pacific Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1743-7563.2011.01464.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1743-7563.2011.01464.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T01:18:52Z","timestamp":1697419132000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1743-7563.2011.01464.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["10.1111\/j.1743-7563.2011.01464.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1743-7563.2011.01464.x","archive":["Portico"],"relation":{},"ISSN":["1743-7555","1743-7563"],"issn-type":[{"value":"1743-7555","type":"print"},{"value":"1743-7563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}